Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia

Journal of Virological Methods

Volumn 193, Issue 1, 2013, Pages 166-168

  Hardie, Diana R ^a   Korsman, Stephen N J ^a   Hsiao, Nei yuan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

CMV viral load; Human cytomegalovirus; Pp65 antigenaemia

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65;

ARTICLE; BLOOD; CELL COUNT; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; ORGAN TRANSPLANTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; VIRUS LOAD; VIRUS REACTIVATION;

CMV VIRAL LOAD; HUMAN CYTOMEGALOVIRUS; PP65 ANTIGENAEMIA;

CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HEMATOLOGIC NEOPLASMS; HIV INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; PHOSPHOPROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION; VIRAL LOAD; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 84880014313     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.06.019     Document Type: Article

References (16)

1. Caliendo A.M., St George K., Allega J., Bullotta A.C., Gilbane L., Rinaldo C.R. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J. Clin. Microbiol. 2002, 40:1581-1586.
2. Cardeñoso L., Pinsky B., Lautenschlager I., Aslam S., Cobb B., Vilchez R., Hirsch H.H. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients. J. Clin. Virol. 2013, 56:108-112.
3. Chakravarti A., Tewari S., Bhalla P. Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India. J. Int. Assoc. Physicians AIDS Care 2010, 9:94-97.
4. Freyer, J.F., Heath, A.B., Anderson, R., Minor, P.D., 2010. Collaborative Study Group: Collaborative study to evaluate the proposed 1st WHO International standard for Human Cytomegalovirus for nucleic acid amplification based assays. WHO/BS/10.2138, Geneva, 18-22 October 2010, p 1-40.
5. Gerna G., Lilleri D., Caldera D., Furione M., Zenone Bragotti L., Alessandrino E.P. Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients. Bone Marrow Transpl. 2008, 41:873-879.
6. Gerna G., Lilleri D. Monitoring transplant patients for human cytomegalovirus: diagnostic update. Herpes 2006, 13:4-11.
7. Goussard P., Kling S., Gie R.P., Nel E.D., Heyns L., Rossouw G.J., Janson J.T. CMV pneumonia in HIV-infected ventilated infants. Pediatr. Pulm 2010, 45:650-655.
8. Kraft C.S., Armstrong W.S., Caliendo A.M. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin. Infect. Dis. 2012, 54:1793-1797.
9. Lilleri D., Gerna G., Furione M., Bernardo M.E., Giorgiani G., Telli S., Baldanti F., Locatelli F. Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. Blood 2007, 110:2757-2760.
10. Mori T., Mori S., Kanda Y., Yakushiji K., Mineishi S., Takaue Y., Gondo H., Harada M., Sakamaki H., Yajima T., Iwao Y., Hibi T., Okamoto S. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2004, 33:431-434.
11. Mujtaba S., Varma S., Sehgal S. Cytomegalovirus co-infection in patients with HIV/AIDS in north India. Indian J. Med. Res. 2003, 117:99-103.
12. Pang X., Chui L., Fenton J. LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood. J. Clin. Microbiol. 2003, 41:3167-3174.
13. Piiparinen H., Höckerstedt K., Grönhagen-Riska C., Lautenschlager I. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J. Clin. Virol. 2004, 30:258-266.
14. Revello M.G., Percivalle E., Arbustini E., Pardi R., Sozzani S., Gerna G. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J. Clin. Invest. 1998, 101:2686-2692.
15. Reynes J., Montes B., Atoui N., Segondy M. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients. J. Med. Virol. 1996, 49:195-198.
16. Strippoli G., Hodson E., Jones C., Craig J. Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation 2006, 81:139-145.